Literature DB >> 24534135

The dynamic detection of NO during the ischemic postconditioning against global cerebral ischemia/reperfusion injury.

Kezhou Liu1, Ming Yan2, Xiaoxiang Zheng3, Yong Yang4.   

Abstract

Little is known about role of Nitric Oxide (NO) of ischemic postconditioning in global cerebral ischemia and reperfusion (I/R) injury. In this study, we detected the dynamic change of NO during the ischemic postconditioning against global cerebral I/R in vivo, and compared the effects of six postconditioning conditions with different numbers of cycles and periods for reperfusion/occlusion. The animals underwent postconditioning consisting of 3 or 10 cycles of 15-s reperfusion, followed by 15-s occlusion (post-3-15/15, post-10-15/15), or 3 or 10 cycles of 30-s reperfusion/30-s occlusion (post-3-30/30, post-10-30/30), or 3 or 10 cycles of 60-s reperfusion/15-s occlusion (post-3-60/15, post-10-60/15). The results showed that four groups increased NO concentration, while all groups improved CBF significantly. Different postconditioning groups had different effects on NO and CBF. Post-3-30/30 had the strongest effect on both. Also it reduced infarct size from 33.0% to 24.29%, and downregulated the cell death ratio from 6.71% to 1.04%, showing the strongest protective effect among tested conditions. And we found that post-3-30/30 was an optional method in ischemic postconditioning, which obviously induced a large amount of NO synthesis with a slow speed, increased CBF and reduced the brain injuries. Therefore we concluded that NO is a reliable candidate in mediating ischemic postconditioning neuroprotection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Global cerebral ischemia; Ischemic postconditioning; Nitric Oxide

Mesh:

Substances:

Year:  2014        PMID: 24534135     DOI: 10.1016/j.niox.2014.02.002

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  7 in total

1.  Evolving possible link between PI3K and NO pathways in neuroprotective mechanism of ischemic postconditioning in mice.

Authors:  Puja Gulati; Nirmal Singh
Journal:  Mol Cell Biochem       Date:  2014-08-24       Impact factor: 3.396

2.  Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation.

Authors:  Mingjin Jiang; Jing Li; Qiuxian Peng; Yi Liu; Wei Liu; Chaohua Luo; Ju Peng; Junkui Li; Ken Kin Lam Yung; Zhixian Mo
Journal:  J Neuroinflammation       Date:  2014-09-26       Impact factor: 8.322

3.  Effect of the PGD2-DP signaling pathway on primary cultured rat hippocampal neuron injury caused by aluminum overload.

Authors:  Jie Ma; Qunfang Yang; Yuling Wei; Yang Yang; Chaonan Ji; Xinyue Hu; Shaoshan Mai; Shengnan Kuang; Xiaoyan Tian; Ying Luo; Guojuan Liang; Junqing Yang
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

4.  The effects of 7-nitroindazole on serum neuron-specific enolase and astroglia-derived protein (S100β) levels after traumatic brain injury.

Authors:  Nan Dong; Yi Diao; Maohua Ding; Baoqiang Cao; Dehua Jiang
Journal:  Exp Ther Med       Date:  2017-04-28       Impact factor: 2.447

Review 5.  Overview of Experimental and Clinical Findings regarding the Neuroprotective Effects of Cerebral Ischemic Postconditioning.

Authors:  Di Ma; Liangshu Feng; Fang Deng; Jia-Chun Feng
Journal:  Biomed Res Int       Date:  2017-04-04       Impact factor: 3.411

Review 6.  Roles of Nitric Oxide in Brain Ischemia and Reperfusion.

Authors:  Yijie Wang; Fenfang Hong; Shulong Yang
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

7.  The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels.

Authors:  Suna Aydin; Tuncay Kuloglu; Suleyman Aydin; Meltem Yardim; Davut Azboy; Zeki Temizturk; Ali Kemal Kalkan; Mehmet Nesimi Eren
Journal:  Cardiovasc J Afr       Date:  2017-08-31       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.